Fiona Russell

Lessons learnt during the COVID-19 pandemic: Why Australian schools should be prioritised to stay open

Archana Koirala, Sharon Goldfeld, Asha C Bowen, Catherine Choong, Kathleen Ryan, Nicholas Wood, Noni Winkler, Margie Danchin, Kristine Macartney, Fiona M Russell

Journal article  |  2021  |  JOURNAL OF PAEDIATRICS AND CHILD HEALTH

In 2020, school and early childhood educational centre (ECEC) closures affected over 1.5 billion school-aged children globally as ..

Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People's Democratic Republic.

Jocelyn Chan, Jana YR Lai, Cattram D Nguyen, Keoudomphone Vilivong, Eileen M Dunne, Audrey Dubot-Pérès, Kimberley Fox, Jason Hinds, Kerryn A Moore, Monica L Nation, Casey L Pell, Anonh Xeuatvongsa, Manivanh Vongsouvath, Paul N Newton, Kim Mulholland, Catherine Satzke, David AB Dance, Fiona M Russell, undefined PneuCAPTIVE Lao PDR Research Group

Journal article  |  2021  |  BMJ Glob Health

INTRODUCTION: Empiric data on indirect (herd) effects of pneumococcal conjugate vaccines (PCVs) in settings with low or heterogene..

Nasopharyngeal Pneumococcal Colonization Density is Associated with Severe Pneumonia in Young Children in the Lao PDR.

OJJ Carr, K Vilivong, L Bounvilay, EM Dunne, JYR Lai, J Chan, M Vongsakid, A Chanthongthip, C Siladeth, B Ortika, C Nguyen, M Mayxay, PN Newton, K Mulholland, LAH Do, A Dubot-Pérès, C Satzke, DAB Dance, FM Russell

Journal article  |  2021  |  J Infect Dis

BACKGROUND: No studies have explored the association between pneumococcal nasopharyngeal density and severe pneumonia using the WH..

Human Papillomavirus Vaccination After COVID-19

Zheng Quan Toh, Fiona M Russell, Suzanne M Garland, Edward K Mulholland, George Patton, Paul Licciardi

Journal article  |  2021  |  JNCI CANCER SPECTRUM

The current global novel coronavirus disease 2019 (COVID-19) pandemic threatens to derail the uptake of human papillomavirus (HPV)..

Genotype Diversity before and after the Introduction of a Rotavirus Vaccine into the National Immunisation Program in Fiji

Sarah Thomas, Celeste M Donato, Sokoveti Covea, Felisita T Ratu, Adam WJ Jenney, Rita Reyburn, Aalisha Sahu Khan, Eric Rafai, Varja Grabovac, Fatima Serhan, Julie E Bines, Fiona M Russell

Journal article  |  2021  |  PATHOGENS

The introduction of the rotavirus vaccine, Rotarix, into the Fiji National Immunisation Program in 2012 has reduced the burden of ..

COVID-19, children and schools: overlooked and at risk

Kathleen E Ryan, Sharon Goldfield, Margie H Danchin, Fiona Russell

Journal article  |  2021  |  MEDICAL JOURNAL OF AUSTRALIA

The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji

Adam WJ Jenney, Rita Reyburn, Felisita T Ratu, Evelyn Tuivaga, Cattram Nguyen, Sokoveti Covea, Sarah Thomas, Eric Rafai, Rachel Devi, Kathryn Bright, Kylie Jenkins, Beth Temple, Lisi Tikoduadua, Joe Kado, E Kim Mulholland, Carl D Kirkwood, Kimberley K Fox, Julie E Bines, Varja Grabovac, Aalisha Sahu Khan, et al.

Journal article  |  2021  |  LANCET REGIONAL HEALTH-WESTERN PACIFIC

Background: In 2012, Fiji became the first independent Pacific island country to introduce rotavirus vaccine. We describe the impa..

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis

Rita Reyburn, Evelyn Tuivaga, Cattram D Nguyen, Felisita T Ratu, Devina Nand, Joe Kado, Lisi Tikoduadua, Kylie Jenkins, Margaret de Campo, Mike Kama, Rachel Devi, Eric Rafai, Daniel M Weinberger, E Kim Mulholland, Fiona M Russell

Journal article  |  2021  |  LANCET GLOBAL HEALTH

BACKGROUND: In October, 2012, Fiji introduced routine infant immunisation with a ten-valent pneumococcal conjugate vaccine (PCV10)..

Who should be prioritised for COVID-19 vaccination?

Fiona M Russell, Brian Greenwood

Journal article  |  2020  |  HUMAN VACCINES & IMMUNOTHERAPEUTICS

The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 month..

Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method

Zheng Quan Toh, Laura He, Catherine Chen, Angela Huang, Fiona M Russell, Suzanne M Garland, Rita Reyburn, Tupou Ratu, Evelyn Tuivaga, Ian H Frazer, E Kim Mulholland, Paul V Licciardi

Journal article  |  2020  |  FRONTIERS IN IMMUNOLOGY

Human papillomavirus (HPV) vaccines are safe and effective in preventing HPV infection and cervical precancers. Neutralizing antib..